Suchergebnisse - "Hart, Robert G"

PubPharm (30)

1

Aspirin Use and Risk of Subdural Hematoma : Updated Meta-Analysis of Randomized Trials

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021

von Hart, R. | Pearce, L. | Gorelick, P. | +2

2

New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention

enthalten in: JAMA neurology | 2020

von Katsanos, A. | Hart, R.

3

Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial : Recurrent stroke risk and response to antithrombotic therapy

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2020

von Ameriso, S. | Amarenco, P. | Pearce, L. | +16

4

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2018

von Kasner, S. | Lavados, P. | Sharma, M. | +43

5

Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation : Drugs and Doses

enthalten in: The Canadian journal of cardiology | 2016

von Kilickap, M. | Bosch, J. | Eikelboom, J. | +1

6

Global survey of the diagnostic evaluation and management of cryptogenic ischemic stroke

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2015

von Giruparajah, M. | Bosch, J. | Vanassche, T. | +4

7

Risk of ischaemic stroke according to pattern of atrial fibrillation : analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

enthalten in: European heart journal | 2015

von Vanassche, T. | Lauw, M. | Eikelboom, J. | +10

CommentIn: Eur Heart J. 2015 Feb 1;36(5):265-6. - PMID 25354518

8

Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation : a secondary analysis of the AVERROES study

enthalten in: Stroke | 2014

von Lip, G. | Eikelboom, J. | Yusuf, S. | +4

9

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

enthalten in: European heart journal | 2013

von Coppens, M. | Eikelboom, J. | Hart, R. | +5

CommentIn: Eur Heart J. 2013 Jan;34(3):168-9. - PMID 23132610

10

Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin : the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial

enthalten in: Stroke | 2012

von Flaker, G. | Eikelboom, J. | Shestakovska, O. | +7